BETRF BETTERLIFE PHARMA INC

BetterLife Announces Closing of Private Placement

VANCOUVER, British Columbia, Dec. 07, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB : BETRF / FRA: NPAU) is pleased to announce that it has close

12-07 21:07

BetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Phoenix, Arizona

VANCOUVER, British Columbia, Dec. 02, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on t

12-02 21:06

Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 38.1%

BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) was the target of a significant drop in short interest in October. As of October 15th, there was short interest totalling 35,700 shares, a drop of

10-29 23:52

Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Decreases By 38.1%

BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totalling 35,700 shares, a drop

10-29 03:51

BetterLife Pharma Inc. (OTCMKTS:BETRF) Sees Large Decrease in Short Interest

BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) was the target of a significant drop in short interest during the month of September. As of September 15th, there was short interest totalling 51,5

10-03 16:42

Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives

In parallel with working towards discovering and advancing therapeutic psychedelics, biopharma companies are continuously protecting their findings. The emerging biotech BetterLife Pharma Inc. (OTCQB:

09-28 06:01

BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives

VANCOUVER, British Columbia, Sept. 27, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on

09-27 20:05

BetterLife and Collaborators to Submit Key Joint Research Publication

VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on

09-07 20:07

Study Reveals BetterLife's LSD Analogue Boosts Structural Neuroplasticity Without Hallucinogenic Side Effects

A recent paper has provided new evidence that LSD has outstanding nootropic effects, believed to originate in the drug's neuroplasticity promotion, in both animals and humans. Yet a previous study inv

08-25 03:20

BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity With Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects

VANCOUVER, British Columbia, Aug. 24, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), is an emerging biotech company focused on the development and commercialization of cutting-edge treatments fo

08-24 20:00